Dyfyniad APA

Lynch, K. D., Chapman, R. W., Keshav, S., Montano-Loza, A. J., Mason, A. L., Kremer, A. E., . . . Levy, C. (2020). Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol.

Dyfyniad Arddull Chicago

Lynch, Kate D., et al. "Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases." Clin Gastroenterol Hepatol 2020.

Dyfyniad MLA

Lynch, Kate D., et al. "Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases." Clin Gastroenterol Hepatol 2020.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.